2022
The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials
Croatto G, Vancampfort D, Miola A, Olivola M, Fiedorowicz J, Firth J, Alexinschi O, Gaina M, Makkai V, Soares F, Cavaliere L, Vianello G, Stubbs B, Fusar-Poli P, Carvalho A, Vieta E, Cortese S, Shin J, Correll C, Solmi M. The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials. Molecular Psychiatry 2022, 28: 369-390. PMID: 36138129, PMCID: PMC9493151, DOI: 10.1038/s41380-022-01770-w.Peer-Reviewed Original ResearchConceptsMood disordersPhysical health outcomesBipolar depressionSerotonin-noradrenaline reuptake inhibitorsModerate ESSmall ESPhysical health-related quality of lifeImprove physical healthReuptake inhibitorsBipolar disorderComorbid medical diseasesPsychological interventionsUmbrella reviewHealth outcomesMeta-analysesMoodNon-pharmacological interventionsHigher discontinuation rateMeta-analyses of randomised controlled trialsDepressionHealth-related quality of lifePhysical healthAssociated with negative effectsControlled TrialsDisorders
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
Bandelow B, Zohar J, Hollander E, Kasper S, Möller H, Zohar J, Hollander E, Kasper S, Möller H, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin D, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein D, Lader M, Lecrubier Y, Lépine J, Liebowitz M, Lopez-Ibor J, Marazziti D, Miguel E, Oh K, Preter M, Rupprecht R, Sato M, Starcevic V, Stein D, van Ameringen M, Vega J. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision. The World Journal Of Biological Psychiatry 2008, 9: 248-312. PMID: 18949648, DOI: 10.1080/15622970802465807.Peer-Reviewed Original ResearchConceptsSerotonin-noradrenaline reuptake inhibitorsPost-traumatic stress disorderSelective serotonin reuptake inhibitorsObsessive-compulsive disorderPharmacological treatmentCognitive behavioral therapyReuptake inhibitorsStress disorderTricyclic antidepressantsSSRI/SNRIAnxiety disordersBiological Psychiatry (WFSBP) GuidelinesFirst-line treatmentRelapse prevention studySerotonin reuptake inhibitorsTreatment-resistant casesPotential treatment optionSubstance abuse disordersWorld FederationObsessive-CompulsiveStudy of anxiolyticsOpen studySustained efficacyStandard treatmentTreatment options
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply